On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Endo Pharmaceuticals (United States)

InstitutionResearch output, impact & collaborations

Endo Pharmaceuticals (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Endo Pharmaceuticals (United States)?

ScholarIQrecord summary

Endo Pharmaceuticals (United States) is a research organisation in Malvern, US. OpenAlex records 1,078 works and 50,993 citations for it. 296 researchers list it as their most recent affiliation.

How many works does Endo Pharmaceuticals (United States) have?

ScholarIQindexed works

Endo Pharmaceuticals (United States) has 1,078 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Endo Pharmaceuticals (United States) →

How many citations does Endo Pharmaceuticals (United States) have?

ScholarIQcitation count

Endo Pharmaceuticals (United States) has 50,993 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Endo Pharmaceuticals (United States) →

How many researchers are at Endo Pharmaceuticals (United States)?

ScholarIQresearcher count

Endo Pharmaceuticals (United States) has 296 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Endo Pharmaceuticals (United States)?

ScholarIQavg h-index

Endo Pharmaceuticals (United States) has an average h-index of 18 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Endo Pharmaceuticals (United States)?

ScholarIQror

The ROR for Endo Pharmaceuticals (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Endo Pharmaceuticals (United States)?

ScholarIQopenalex

The OpenAlex for Endo Pharmaceuticals (United States) is on the source record.

Open the OpenAlex →

What is the Wikidata of Endo Pharmaceuticals (United States)?

ScholarIQwikidata

The Wikidata for Endo Pharmaceuticals (United States) is on the source record.

Open the Wikidata →

Who are the most-cited researchers behind Endo Pharmaceuticals (United States)?

ScholarIQtop researchers by citations

J. Scott Andrews · Dementia and Cognitive Impairment Research

81 works3,586 citations

What are the most-cited papers on Endo Pharmaceuticals (United States)?

ScholarIQmost cited works

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, Teresa Buracchio, Billy Dunn, Ana Graf, Oskar Hansson, Carole Ho, William J. Jagust, Eric McDade, José Luís Molinuevo, Ozioma C. Okonkwo, Luca Pani, Michael S. Rafii, Philip Scheltens, Eric Siemers, Heather M. Snyder, Reisa A. Sperling, Charlotte E. Teunissen, Marı́a C. Carrillo

Alzheimer s & Dementia. 20242,424 CitationsOPEN ACCESS

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials

J. Scott Andrews, Urvi Desai, Noam Y. Kirson, Miriam L. Zichlin, Daniel Ball, Brandy R. Matthews

Alzheimer s & Dementia Translational Research & Clinical Interventions. 2019333 CitationsOPEN ACCESS

Expectations and clinical meaningfulness of randomized controlled trials

Ronald C. Petersen, Paul Aisen, J. Scott Andrews, Alireza Atri, Brandy R. Matthews, Dorene M. Rentz, Eric Siemers, Christopher J. Weber, María C. Carrillo

Alzheimer s & Dementia. 202392 CitationsOPEN ACCESS

Costs of Early Stage Alzheimer’s Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1

R.L. Robinson, Dorene M. Rentz, J. Scott Andrews, Anthony J. Zagar, Yongin Kim, Valerie Bruemmer, Ronald L. Schwartz, Wenyu Ye, Howard Fillit

Journal of Alzheimer s Disease. 202072 CitationsOPEN ACCESS

Factors associated with long-term impact on informal caregivers during Alzheimer’s disease dementia progression: 36-month results from GERAS

Catherine Reed, Mark Belger, J. Scott Andrews, Antje Tockhorn‐Heidenreich, Roy Jones, Anders Wimo, Richard Dodel, Josep María Haro

International Psychogeriatrics. 201963 CitationsOPEN ACCESS

How much of the research on Endo Pharmaceuticals (United States) is open access?

ScholarIQopen access share

91%OPEN ACCESS

Gold

45%

Green

Hybrid

36%

Bronze

Closed